Studies on the Live-Virus Vaccine against Infectious Laryngotracheitis of Chickens. II. Evaluation of the Tissue-Culture-Modified Strain C7 in Laboratory and Field Trials

1984 ◽  
Vol 28 (2) ◽  
pp. 323 ◽  
Author(s):  
Toshiro Izuchi ◽  
Akira Hasegawa ◽  
Takeshi Miyamoto
1985 ◽  
Vol 29 (3) ◽  
pp. 768 ◽  
Author(s):  
A. M. Fadly ◽  
K. Nazerian ◽  
K. Nagaraja ◽  
G. Below

PEDIATRICS ◽  
1996 ◽  
Vol 98 (4) ◽  
pp. 795-795
Author(s):  
Sanford Schneider

The pro and con commentaries by Drs Judelsohn and Katz (Pediatrics 1996;98:115-117) do not mention projected costs. In these days of limited resources, the greatest bang for the buck is important and perhaps is becoming the most important factor of delivery of medical services to large populations. Developing a single product multi-vaccine containing inactivated polio virus, to be followed by oral live virus vaccine, will unquestionably add to the cost of protection. Also, Dr Katz does not seem to address the problem of compliance.


2017 ◽  
Vol 5 (22) ◽  
Author(s):  
Patricia Renson ◽  
Fabrice Touzain ◽  
Arnaud Lebret ◽  
Mireille Le Dimna ◽  
Hélène Quenault ◽  
...  

ABSTRACT This paper provides information on the complete genome sequence of a porcine reproductive and respiratory syndrome virus (PRRSV) strain isolated on a French pig farm which was identified as a recombinant strain from two commercial modified live virus vaccine strains of genotype 1 (VP-046BIS and DV strains).


Vaccine ◽  
2013 ◽  
Vol 31 (41) ◽  
pp. 4508-4515 ◽  
Author(s):  
Xiangdong Li ◽  
Amy Galliher-Beckley ◽  
Hongzhou Huang ◽  
Xiuzhi Sun ◽  
Jishu Shi

Sign in / Sign up

Export Citation Format

Share Document